IL1A and familial pancreatic carcinoma: Even though animal studies support a therapeutic effect of IL-1RA on pancreatitis (27–29), few trials have examined the effectiveness of IL-1 inhibitors, like anakinra, in treating pancreatitis or pancreatic cancer.